Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qitai Chen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chinese Clinical Oncology|June 11, 2026
Network pharmacology of Sijunzi decoction in pancreatic cancerRujia Zheng, Qitai Chen, Mengting Zhang, et al.
Chinese Clinical Oncology|July 9, 2026
Network pharmacology of Sijunzi decoction in pancreatic cancerRujia Zheng, Qitai Chen, Mengting Zhang, et al.
European Journal of Gastroenterology & Hepatology|April 10, 2025
Association between HALP and all-cause and specific mortality in US adult with nonalcoholic fatty liver disease cirrhosis: a cohort study of National Health and Nutrition Examination Survey 2005-2018Ruifeng Zhang, Gengjia Weng, Jiahao Wang, et al.
Journal of Nanobiotechnology|July 31, 2025
Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinomaWanyue Cao, Kai Yang, Gaowei Jin, et al.
Cancer Letters|April 1, 2026
Postoperative exosomal miR-1246 fuels hepatocellular carcinoma metastasis via BMP9-SMAD7 axis suppressionZhe Zhang, Xishan Yang, Rujia Zheng, et al.
Oncogene|September 10, 2025
A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancerXiaobao Wei, Jiangchao Wu, Wanyue Cao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2025
Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activationZhe Zhang, Qitai Chen, Rujia Zheng, et al.
Translational Oncology|January 21, 2025
Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomasJunli Wang, Yu Lou, Xiaojun Peng, et al.
Cancer Letters|January 25, 2024
Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective studyYangyang Wang, Xu Sun, Cao Chen, et al.
NPJ Precision Oncology|November 14, 2025
Predicting tumor micronecrosis in hepatocellular carcinoma using pretreatment contrast-enhanced CT radiomics model: a multi-center studyYangyang Wang, Chao Huang, Yu Tian, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chinese Clinical Oncology|June 11, 2026
Network pharmacology of Sijunzi decoction in pancreatic cancerRujia Zheng, Qitai Chen, Mengting Zhang, et al.
Chinese Clinical Oncology|July 9, 2026
Network pharmacology of Sijunzi decoction in pancreatic cancerRujia Zheng, Qitai Chen, Mengting Zhang, et al.
European Journal of Gastroenterology & Hepatology|April 10, 2025
Association between HALP and all-cause and specific mortality in US adult with nonalcoholic fatty liver disease cirrhosis: a cohort study of National Health and Nutrition Examination Survey 2005-2018Ruifeng Zhang, Gengjia Weng, Jiahao Wang, et al.
Journal of Nanobiotechnology|July 31, 2025
Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinomaWanyue Cao, Kai Yang, Gaowei Jin, et al.
Cancer Letters|April 1, 2026
Postoperative exosomal miR-1246 fuels hepatocellular carcinoma metastasis via BMP9-SMAD7 axis suppressionZhe Zhang, Xishan Yang, Rujia Zheng, et al.
Oncogene|September 10, 2025
A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancerXiaobao Wei, Jiangchao Wu, Wanyue Cao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2025
Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activationZhe Zhang, Qitai Chen, Rujia Zheng, et al.
Translational Oncology|January 21, 2025
Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomasJunli Wang, Yu Lou, Xiaojun Peng, et al.
Cancer Letters|January 25, 2024
Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective studyYangyang Wang, Xu Sun, Cao Chen, et al.
NPJ Precision Oncology|November 14, 2025
Predicting tumor micronecrosis in hepatocellular carcinoma using pretreatment contrast-enhanced CT radiomics model: a multi-center studyYangyang Wang, Chao Huang, Yu Tian, et al.
Pageof 1